$0.57
-0.03 (-5.42%)
Open$0.60
Previous Close$0.60
Day High$0.60
Day Low$0.54
52W High$15.75
52W Low$0.16
Volume—
Avg Volume1.65M
Market Cap12.64M
P/E Ratio—
EPS$-14.53
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+4,369.2% upside
Current
$0.57
$0.57
Target
$25.43
$25.43
$14.54
$25.43 avg
$32.33
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.53M | 2.25M | 2.34M |
| Net Income | -604,093 | -536,841 | -566,432 |
| Profit Margin | -23.9% | -23.9% | -24.2% |
| EBITDA | -828,287 | -680,626 | -721,197 |
| Free Cash Flow | -326,986 | -310,260 | -424,378 |
| Rev Growth | -6.1% | -2.1% | -7.6% |
| Debt/Equity | 0.51 | 0.64 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |